Team: Bios
Elizabeth Stoner, MD
Managing Director
Dr. Elizabeth Stoner joined MPM in 2007 as Managing Director, following a 22-year career at Merck Research Laboratories. She currently serves as the Chief Development Officer for Rhythm Pharmaceuticals and Vascular Pharmaceuticals. At the time of her retirement from Merck, she was Senior Vice President, Global Clinical Development Operations with responsibility for the company's clinical development activities in more than 40 countries. She also oversaw the clinical development activities of Merck's Japanese partner Banyu, led the clinical development for the Merck/Schering-Plough Joint Venture for Zetia/Vytorin, and played a critical leadership role in efforts to transform Merck's worldwide clinical development operations. Previously, she led the Proscar clinical development program from inception, establishing Merck as a leader in the field of prostate disease. As Endocrine Therapeutic Head, Dr. Stoner's responsibilities included all steroid and lipid metabolism, as well as the growth hormone secretagogue clinical research programs. Prior to Merck, she was an Assistant Professor of Pediatrics, Cornell University Medical College. Dr. Stoner received a B.S. in Chemistry from Ottawa University, KS, an M.S. in Chemistry, State University of New York at Stony Brook; an M.D. from Albert Einstein College of Medicine. She serves on the Boards of Momenta Pharmaceuticals, Radius Health, Albert Einstein College of Medicine - Alumni Board of Governors; and the External Advisory Board of the Weill Cornell Medical College CTSA.
Portfolio Assignments
Solasia K.K.
Rhythm Pharmaceuticals, Inc.
Past Portfolio Assignments
Alnara Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc.